Table 3 Hazard ratios and 95% confidence intervals for mortality according to quartiles of liver enzymes after myocardial infarction or ischemic stroke.

		Event	Duration	MR	Model 1	Model 2
		Event	Duration	MR	HR (95% Cl)	HR (95% Cl)
ALT	Q1	6218	21507006	0.29	1.00 (Ref)	1.00 (Ref)
	Q2	3841	20805510	0.18	0.73 (0.70, 0.76)	0.80 (0.76, 0.83)
	Q3	3571	22471487	0.16	0.70 (0.67, 0.73)	0.80 (0.77, 0.84)
	Q4	3252	21550048	0.15	0.78 (0.74, 0.81)	0.93 (0.89, 0.97)
AST	Q1	5024	23428822	0.21	1.00 (Ref)	1.00 (Ref)
	Q2	3378	18599784	0.18	0.83 (0.80, 0.87)	0.87 (0.83, 0.91)
	Q3	3929	22604257	0.17	0.80 (0.77, 0.83)	0.85 (0.82, 0.89)
	Q4	4551	21702283	0.21	1.02 (0.98, 1.06)	1.09 (1.04, 1.13)
GGT	Q1	4622	20642384	0.22	1.00 (Ref)	1.00 (Ref)
	Q2	4061	21699165	0.19	0.93 (0.89, 0.97)	1.03 (0.99, 1.07)
	Q3	3740	22372024	0.17	0.92 (0.88, 0.96)	1.08 (1.04, 1.13)
	Q4	4459	21619018	0.21	1.24 (1.19, 1.29)	1.46 (1.40, 1.52)

MR, mortality rate (per 1000 person-years); HR, hazard ratio; CI, confidence interval; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, γ-glutamyltransferase.
Model 1: HRs were analyzed after adjusting for age and sex.
Model 2: HRs were analyzed after adjusting for age, sex, body mass index, smoking, alcohol, exercise, diabetes, hypertension, and dyslipidemia.

Quick links

Search